WuXi AppTec is a trusted partner and contributor to the pharmaceutical and life sciences industries, providing R&D and manufacturing services that help advance healthcare innovation. With operations across Asia, Europe, and North America, we offer integrated, end-to-end services through our unique CRDMO (Contract Research, Development, and Manufacturing Organization) platform. We are privileged to work alongside nearly 6,000 partners across 30+ countries, supporting their efforts to bring breakthrough treatments to patients. Guided by our vision that every drug can be made and every disease can be treated, we are committed to advancing breakthroughs for patients—one collaboration at a time. Learn more at www.wuxiapptec.com
Shared 2 months ago
80 views
Shared 5 months ago
87 views
Shared 5 months ago
166 views
Shared 5 months ago
103 views
Shared 5 months ago
83 views
Shared 6 months ago
53 views
Shared 6 months ago
31 views
Shared 6 months ago
94 views
Shared 6 months ago
46 views
Shared 6 months ago
93 views
Shared 6 months ago
213 views
Shared 6 months ago
53 views
Shared 7 months ago
47 views
A Global Village for Global Impact: Talk with Michael Altorfer, CEO of the Swiss Biotech Association
Shared 7 months ago
55 views
Shared 7 months ago
48 views
Shared 3 years ago
33 views
Shared 3 years ago
108 views
Shared 3 years ago
46 views
Shared 3 years ago
54 views
Shared 3 years ago
13 views
Shared 3 years ago
34 views
Shared 3 years ago
12 views
Fragile X Syndrome: Innovative Approaches to Finding a Cure |Targeted Therapy (Christopher Missling)
Shared 3 years ago
191 views
Shared 3 years ago
10 views
Shared 3 years ago
52 views
Fragile X Syndrome: Innovative Approaches to Finding a Cure |Targeted Therapy Adrian Newman-Tancredi
Shared 3 years ago
12 views
Shared 3 years ago
41 views
Shared 3 years ago
44 views
Shared 3 years ago
25 views
Shared 3 years ago
8 views
Shared 3 years ago
13 views
Shared 3 years ago
12 views
Shared 3 years ago
8 views
Shared 3 years ago
33 views
Shared 3 years ago
59 views
Shared 3 years ago
6 views
Shared 3 years ago
21 views
Shared 3 years ago
5 views
Shared 3 years ago
6 views
Shared 3 years ago
14 views
Shared 3 years ago
8 views
Shared 3 years ago
18 views
Shared 3 years ago
8 views
Shared 3 years ago
15 views
Shared 3 years ago
6 views